2BB score and signals
Oruka Therapeutics, Inc.’s current 2BB score is 36 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 67 | High |
| Momentum | 52 | Stable |
| Financial strength | 32 | Weak |
| Quality | 81 | Very Strong |
| Risk | 37 | Low |
Company facts
| Headquarters | Westminster, Colorado, United States |
| Founded | 2024 |
| Employees | 68 |
| 52-week range | $25.11 – $115.51 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-10 | — | -0.6578 | — | $0.00 |
| 2026-11-10 | — | -0.6177 | — | $0.00 |
| 2026-08-10 | -0.55 | -0.5257 | $0.00 | $0.00 |
| 2026-05-13 | -0.48 | -0.5602 | $0.00 | $0.00 |
Related companies
